Molecular characterization of Neisseria gonorrhoeae identifies transmission and resistance of one ciprofloxacin-resistant strain
- PMID: 17367469
- PMCID: PMC2769514
- DOI: 10.1111/j.1600-0463.2007.apm_487.x
Molecular characterization of Neisseria gonorrhoeae identifies transmission and resistance of one ciprofloxacin-resistant strain
Abstract
A highly discriminative and objective genetic characterization of N. gonorrhoeae, which increases our knowledge of strain populations in different geographic areas, is crucial for the development of improved control measures. In the present study, conventional phenotypic characterization and genetic characterization by means of pulsed-field gel electrophoresis (PFGE), sequencing of the entire porB gene, N. gonorrhoeae multiantigen sequence typing (NG-MAST), and pyrosequencing of a quinolone resistance determining region (QRDR) of the gyrA gene of Swedish ciprofloxacin-resistant N. gonorrhoeae serovar IB-10 isolates (n=45) were performed. The genetic characterization identified one widely spread ciprofloxacin-resistant N. gonorrhoeae ST147 strain. In addition, isolates with slightly different genetic characteristics, which presumably reflect the ongoing evolution only, were also identified. All the isolates contained single nucleotide polymorphisms in QRDR of the gyrA gene that are highly correlated with ciprofloxacin resistance. Consequently, comprehensive characterization identified the first confirmed large domestic transmission, mainly among young heterosexuals, of one ciprofloxacin-resistant N. gonorrhoeae strain in Swedish society during 2002-2003. In conclusion, a precise, i.e. genetic, characterization for identification of individual strains is a very valuable support to the crucial active surveillance of the epidemiological characteristics and the antibiotic susceptibility of N. gonorrhoeae in the effective treatment of gonorrhoea.
Figures

Similar articles
-
Molecular epidemiology of Neisseria gonorrhoeae- identification of the first presumed Swedish transmission chain of an azithromycin-resistant strain.APMIS. 2006 Jan;114(1):67-71. doi: 10.1111/j.1600-0463.2006.apm_332.x. APMIS. 2006. PMID: 16499664
-
Characterization of ciprofloxacin resistance in Neisseria gonorrhoeae isolates in Canada.Sex Transm Dis. 2002 Dec;29(12):780-8. doi: 10.1097/00007435-200212000-00008. Sex Transm Dis. 2002. PMID: 12466720
-
Antimicrobial susceptibility/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland, 2010-2012.BMC Infect Dis. 2014 Feb 6;14:65. doi: 10.1186/1471-2334-14-65. BMC Infect Dis. 2014. PMID: 24502606 Free PMC article.
-
Dissemination and genome analysis of high-level ceftriaxone-resistant penA 60.001 Neisseria gonorrhoeae strains from the Guangdong Gonococcal antibiotics susceptibility Programme (GD-GASP), 2016-2019.Emerg Microbes Infect. 2022 Dec;11(1):344-350. doi: 10.1080/22221751.2021.2011618. Emerg Microbes Infect. 2022. PMID: 34994305 Free PMC article.
-
Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century.Med Microbiol Immunol. 2020 Apr;209(2):95-108. doi: 10.1007/s00430-019-00651-4. Epub 2019 Dec 4. Med Microbiol Immunol. 2020. PMID: 31802195 Free PMC article. Review.
Cited by
-
New Clinical Strain of Neisseria gonorrhoeae with Decreased Susceptibility to Ceftriaxone, Japan.Emerg Infect Dis. 2016 Jan;22(1):142-4. doi: 10.3201/eid2201.150868. Emerg Infect Dis. 2016. PMID: 26689442 Free PMC article. No abstract available.
-
The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization.J Antimicrob Chemother. 2016 Nov;71(11):3096-3108. doi: 10.1093/jac/dkw288. Epub 2016 Jul 17. J Antimicrob Chemother. 2016. PMID: 27432602 Free PMC article.
-
In vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants: ertapenem for treatment of gonorrhea?Antimicrob Agents Chemother. 2012 Jul;56(7):3603-9. doi: 10.1128/AAC.00326-12. Epub 2012 Apr 30. Antimicrob Agents Chemother. 2012. PMID: 22547617 Free PMC article.
-
Antibiograms and randomly amplified polymorphic DNA-polymerase chain reactions (RAPD-PCR) as epidemiological markers of gonorrhea.J Clin Lab Anal. 2010;24(1):31-7. doi: 10.1002/jcla.20355. J Clin Lab Anal. 2010. PMID: 20087948 Free PMC article.
-
Phenotypic and genotypic properties of Neisseria gonorrhoeae isolates in Norway in 2009: antimicrobial resistance warrants an immediate change in national management guidelines.Eur J Clin Microbiol Infect Dis. 2012 Jun;31(6):1181-6. doi: 10.1007/s10096-011-1426-4. Epub 2011 Sep 30. Eur J Clin Microbiol Infect Dis. 2012. PMID: 21960034
References
-
- Tapsall J. Antimicrobial resistance in Neisseria gonorrhoeae. World Health Organization (WHO) report 2001. WHO/CDS/CSR/DSR/2001.3.
-
- Berglund T, Unemo M, Olcén P, Giesecke J, Fredlund H. One year of Neisseria gonorrhoeae isolates in Sweden: the prevalence study of antibiotic susceptibility shows relation to the geographic area of exposure. Int J STD AIDS. 2002;13:109–14. - PubMed
-
- Centers for Disease Control and Prevention (CDC) Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men – United States, 2003, and revised recommendations for gonorrhea treatment, 2004. MMWR Morb Mortal Wkly Rep. 2004;53:335–8. - PubMed
-
- Martin IM, Hoffmann S, Ison CA. European Surveillance of Sexually Transmitted Infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe. J Antimicrob Chemother. 2006;58:587–93. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases